Onderneming Oramed Pharmaceuticals, Inc. Xetra
Aandelen
OJU
US68403P1049
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- EUR | - |
|
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Solutions
100,0
%
| 3 | 100,0 % | 1 | 100,0 % | -50,43% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 3 | 100,0 % | 1 | 100,0 % | -50,43% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12-04-02 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12-04-02 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14-04-13 |
Leonard Sank
BRD | Director/Board Member | 59 | 23-10-07 |
Zach Herschfus
IRC | Investor Relations Contact | - | - |
Netanel Derovan
LAW | General Counsel | - | 09-01-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12-04-02 |
Miriam Kidron
FOU | Founder | 83 | 12-04-02 |
Leonard Sank
BRD | Director/Board Member | 59 | 23-10-07 |
Arie Mayer
BRD | Director/Board Member | 67 | 05-12-19 |
Benjamin Shapiro
BRD | Director/Board Member | 40 | 01-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 40 628 924 | 35 961 754 ( 88,51 %) | 0 | 88,51 % |
Bedrijfsgegevens
Oramed Pharmaceuticals, Inc.
1185 Avenue of the Americas 3rd Floor
10036, New York
+844 967 2633
http://www.oramed.com![Adres Oramed Pharmaceuticals, Inc.(OJU)](https://cdn.zonebourse.com/static/address/493413.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,87% | 52,73 mld. | |
+37,35% | 39 mld. | |
-9,45% | 38,52 mld. | |
+27,44% | 30,38 mld. | |
-12,26% | 26,39 mld. | |
+10,73% | 26,08 mld. | |
+44,44% | 14,15 mld. | |
+32,12% | 12,6 mld. | |
-5,38% | 11,51 mld. |
- Beurs
- Aandelen
- Koers ORMP
- Koers OJU
- Onderneming Oramed Pharmaceuticals, Inc.